Patient Preferences for Use of Archived Biospecimens from Oncology Trials When Adequacy of Informed Consent Is Unclear
Authors:
- Jeffrey PeppercornJPJeffrey Peppercorn
- Eric CampbellECEric Campbell
- Nora K. HorickNHNora K. Horick
- Julia RabinJRJulia Rabin
- Katharine QuainKQKatharine Quain
- Lecia V. SequistLSLecia V. Sequist
- Aditya BardiaABAditya Bardia
- Deborah CollyarDCDeborah Collyar
- Fay HlubockyFHFay Hlubocky
- Debra MathewsDMDebra Mathews
Open Access
- 6 September 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 25 (1) , 78-86
Abstract
Background: Oncology research increasingly involves biospecimen collection and data sharing. Ethical challenges emerge when researchers seek to use archived biospecimens for purposes that were not well defined in the original informed consent document (ICD). We sought to inform ongoing policy debates by assessing patient views on these issues. Materials and Methods: We administered a cross-sectional self-administered survey to patients with cancer at an academic medical center. Survey questions addressed attitudes toward cancer research, willingness to donate biospecimens, expectations regarding use of biospecimens, and preferences regarding specific ethical dilemmas. Results: Among 240 participants (response rate 69%), virtually all (94%) indicated willingness to donate tissue for research. Most participants (86%) expected that donated tissue would be used for any research deemed scientifically important, and virtually all (94%) expected that the privacy of their health information would be protected. Broad use of stored biospecimens and data sharing with other researchers increased willingness to donate tissue. For three scenarios in which specific consent for proposed biobank research was unclear within the ICD, a majority of patient's favored allowing the research to proceed: 76% to study a different cancer, 88% to study both inherited (germline) and tumor specific (somatic) mutations, and 70% to permit data sharing. A substantial minority believed that research using stored biospecimens should only proceed with specific consent. Conclusion: When debates arise over appropriate use of archived biospecimens, the interests of the research participants in seeing productive use of their blood or tissue should be considered, in addition to addressing concerns about potential risks and lack of specific consent.Keywords
Funding Information
- Greenwall Foundation for Bioethics
This publication has 35 references indexed in Scilit:
- Biobanking research on oncological residual material: a framework between the rights of the individual and the interest of societyBMC Medical Ethics, 2013
- Public Knowledge of and Attitudes Toward Genetics and Genetic TestingGenetic Testing and Molecular Biomarkers, 2013
- Ethical aspects of participation in the Database of Genotypes and Phenotypes of the National Center for Biotechnology InformationCancer, 2012
- Patients’ Attitudes to Informed Consent for Genomic Research With Donated SamplesCancer Investigation, 2010
- The role of race and trust in tissue/blood donation for genetic researchGenetics in Medicine, 2010
- The ethical use of existing samples for genome researchGenetics in Medicine, 2009
- Resolving Individuals Contributing Trace Amounts of DNA to Highly Complex Mixtures Using High-Density SNP Genotyping MicroarraysPLOS Genetics, 2008
- Attitudes and perceptions of patients towards methods of establishing a DNA biobankCell and Tissue Banking, 2007
- Research on stored biological samples: Views of African American and White American cancer patientsAmerican Journal of Medical Genetics Part A, 2006
- Quality of informed consent in cancer clinical trials: a cross-sectional surveyThe Lancet, 2001